Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Sharp

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|May 13, 2026
Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunitiesNick R Waldron, Diogo Silva, Daniel Westaby, et al.
European Urology|August 29, 2022
Re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86 AR-V7 is Rare in Hormone-sensitive Prostate Cancer: AR-V7 is Rare in Hormone-sensitive Prostate CancerAdam G Sowalsky, Stephen R Plymate, Michael C Haffner, et al.
Cancer Treatment and Research Communications|January 31, 2021
AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualificationAdam G Sowalsky, Adam Sharp, Shana Y Trostel, et al.
BMC Public Health|September 10, 2014
Text messaging as a community-based survey tool: a pilot studyTammy Chang, Weyinshet Gossa, Adam Sharp, et al.
Journal of General Internal Medicine|June 23, 2019
Impact of Social Needs Navigation on Utilization Among High Utilizers in a Large Integrated Health System: a Quasi-experimental StudyAdam Schickedanz, Adam Sharp, Yi R Hu, et al.
Cancers|May 11, 2024
Inter- and Intra-Patient Repeatability of Radiomic Features from Multiparametric Whole-Body MRI in Patients with Metastatic Prostate CancerRicardo Donners, Antonio Candito, Mihaela Rata, et al.
Expert Reviews in Molecular Medicine|March 23, 2004
BAG-1 in carcinogenesisAdam Sharp, Simon J Crabb, Paul A Townsend, et al.
Cancers|January 11, 2022
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate CancerDaniel Westaby, Juan M Jimenez-Vacas, Ana Padilha, et al.
Nature Reviews. Urology|October 14, 2025
Therapeutic targeting of prostate-specific membrane antigen could limit its potential as benchmark imagingMelissa L Abel, Adam Sharp, Edwin M Posadas, et al.
Clinical Genitourinary Cancer|June 14, 2017
Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral CorticosteroidsNiven Mehra, Adam Sharp, David Lorente, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|May 13, 2026
Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunitiesNick R Waldron, Diogo Silva, Daniel Westaby, et al.
European Urology|August 29, 2022
Re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86 AR-V7 is Rare in Hormone-sensitive Prostate Cancer: AR-V7 is Rare in Hormone-sensitive Prostate CancerAdam G Sowalsky, Stephen R Plymate, Michael C Haffner, et al.
Cancer Treatment and Research Communications|January 31, 2021
AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualificationAdam G Sowalsky, Adam Sharp, Shana Y Trostel, et al.
BMC Public Health|September 10, 2014
Text messaging as a community-based survey tool: a pilot studyTammy Chang, Weyinshet Gossa, Adam Sharp, et al.
Journal of General Internal Medicine|June 23, 2019
Impact of Social Needs Navigation on Utilization Among High Utilizers in a Large Integrated Health System: a Quasi-experimental StudyAdam Schickedanz, Adam Sharp, Yi R Hu, et al.
Cancers|May 11, 2024
Inter- and Intra-Patient Repeatability of Radiomic Features from Multiparametric Whole-Body MRI in Patients with Metastatic Prostate CancerRicardo Donners, Antonio Candito, Mihaela Rata, et al.
Expert Reviews in Molecular Medicine|March 23, 2004
BAG-1 in carcinogenesisAdam Sharp, Simon J Crabb, Paul A Townsend, et al.
Cancers|January 11, 2022
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate CancerDaniel Westaby, Juan M Jimenez-Vacas, Ana Padilha, et al.
Nature Reviews. Urology|October 14, 2025
Therapeutic targeting of prostate-specific membrane antigen could limit its potential as benchmark imagingMelissa L Abel, Adam Sharp, Edwin M Posadas, et al.
Clinical Genitourinary Cancer|June 14, 2017
Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral CorticosteroidsNiven Mehra, Adam Sharp, David Lorente, et al.
Pageof 12